Hyperlipidemia-induced oxidative stress is considered to be one of the main pathogenic factors that contribute to pancreatic beta cell dysfunction in the development of type 2 diabetes (T2D). Sirtuin 3 (Sirt3) is abundantly expressed in the mitochondria as an NAD+-dependent deacetylase and regulates mitochondrial adaptive responses to oxidative stress. We examined the antioxidant defense mechanism of Sirt3 in pancreatic beta cells in the context of hyperlipidemia.
Results:
Chronic high-fat diet (HFD) feeding caused elevated oxidative stress accompanied by reduced Sirt3 expression in the pancreatic beta cells of wild-type mice. Primary pancreatic islets of Sirt3 knockout (KO) mice and murine pancreatic MIN6 cells with downregulated Sirt3 expression showed increased superoxide dismutase 2 (SOD2) acetylation and reduced glucose-stimulated insulin secretion and glucose-stimulated adenosine triphosphate (ATP) generation. Moreover, Sirt3 deficiency sensitized the pancreatic islets and MIN6 cells to palmitate- and H2O2-induced beta cell dysfunction linked with aggravated c-Jun N-terminal kinase phosphorylation and cleaved caspase-3 expression. These negative effects were reversed by antioxidant chemical treatment or restoration of Sirt3 in KO islets. Finally, overexpression of Sirt3 in MIN6 cells partially rescued palmitate-induced reactive oxygen species generation, pancreatic and duodenal homeobox-1 (Pdx-1) nucleo-cytoplasmic translocation, and beta cell dysfunction.
Innovation:
We present that Sirt3 expression protected pancreatic beta cells from lipotoxicity by antagonizing oxidative stress-induced cell damage.
Conclusion:
These results suggest that Sirt3 may be a target for amelioration of beta cell dysfunction due to obesity and T2D. Antioxid. Redox Signal. 27, 962–976.
Get full access to this article
View all access options for this article.
References
1.
American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care, 33Suppl 1: S62–S69, 2010.
2.
AhnBH, KimHS, SongS, LeeIH, LiuJ, VassilopoulosA, DengCX, and FinkelT. A role for the mitochondrial deacetylase Sirt3 in regulating energy homeostasis. Proc Natl Acad Sci U S A, 105: 14447–14452, 2008.
3.
AubervalN, DalS, BietigerW, PingetM, JeandidierN, Maillard-PedraciniE, Schini-KerthV, and SigristS. Metabolic and oxidative stress markers in Wistar rats after 2 months on a high-fat diet. Diabetol Metab Syndr, 6: 130, 2014.
4.
BaoJ, LuZ, JosephJJ, CarabenciovD, DimondCC, PangL, SamselL, McCoyJPJr., LeclercJ, NguyenP, GiusD, and SackMN. Characterization of the murine SIRT3 mitochondrial localization sequence and comparison of mitochondrial enrichment and deacetylase activity of long and short SIRT3 isoforms. J Cell Biochem, 110: 238–247, 2010.
5.
BonnyC, ObersonA, NegriS, SauserC, and SchorderetDF. Cell-permeable peptide inhibitors of JNK: novel blockers of beta-cell death. Diabetes, 50: 77–82, 2001.
CatonPW, RichardsonSJ, KieswichJ, BuglianiM, HollandML, MarchettiP, MorganNG, YaqoobMM, HolnessMJ, and SugdenMC. Sirtuin 3 regulates mouse pancreatic beta cell function and is suppressed in pancreatic islets isolated from human type 2 diabetic patients. Diabetologia, 56: 1068–1077, 2013.
9.
CnopM, WelshN, JonasJC, JornsA, LenzenS, and EizirikDL. Mechanisms of pancreatic beta-cell death in type 1 and type 2 diabetes: many differences, few similarities. Diabetes, 54Suppl 2: S97–S107, 2005.
10.
De TataV. Age-related impairment of pancreatic Beta-cell function: pathophysiological and cellular mechanisms. Front Endocrinol (Lausanne), 5: 138, 2014.
11.
DrewsG, Krippeit-DrewsP, and DuferM. Oxidative stress and beta-cell dysfunction. Pflugers Arch, 460: 703–718, 2010.
12.
Fernandez-MarcosPJ, JeningaEH, CantoC, HarachT, de BoerVC, AndreuxP, MoullanN, PirinenE, YamamotoH, HoutenSM, SchoonjansK, and AuwerxJ. Muscle or liver-specific Sirt3 deficiency induces hyperacetylation of mitochondrial proteins without affecting global metabolic homeostasis. Sci Rep, 2: 425, 2012.
13.
GolsonML, MisfeldtAA, KopsombutUG, PetersenCP, and GannonM. High fat diet regulation of beta-cell proliferation and beta-cell mass. Open Endocrinol J, 4, 2010.
14.
HirscheyMD, ShimazuT, JingE, GrueterCA, CollinsAM, AouizeratB, StancakovaA, GoetzmanE, LamMM, SchwerB, StevensRD, MuehlbauerMJ, KakarS, BassNM, KuusistoJ, LaaksoM, AltFW, NewgardCB, FareseRVJr., KahnCR, and VerdinE. SIRT3 deficiency and mitochondrial protein hyperacetylation accelerate the development of the metabolic syndrome. Mol Cell, 44: 177–190, 2011.
15.
HouN, ToriiS, SaitoN, HosakaM, and TakeuchiT. Reactive oxygen species-mediated pancreatic beta-cell death is regulated by interactions between stress-activated protein kinases, p38 and c-Jun N-terminal kinase, and mitogen-activated protein kinase phosphatases. Endocrinology, 149: 1654–1665, 2008.
16.
IizukaK, NakajimaH, OnoA, OkitaK, MiyazakiJ, MiyagawaJ, NambaM, HanafusaT, and MatsuzawaY. Stable overexpression of the glucose-6-phosphatase catalytic subunit attenuates glucose sensitivity of insulin secretion from a mouse pancreatic beta-cell line. J Endocrinol, 164: 307–314, 2000.
17.
KanetoH and MatsuokaTA. Involvement of oxidative stress in suppression of insulin biosynthesis under diabetic conditions. Int J Mol Sci, 13: 13680–13690, 2012.
18.
KanetoH and MatsuokaTA. Role of pancreatic transcription factors in maintenance of mature beta-cell function. Int J Mol Sci, 16: 6281–6297, 2015.
19.
KanetoH, MatsuokaTA, KatakamiN, KawamoriD, MiyatsukaT, YoshiuchiK, YasudaT, SakamotoK, YamasakiY, and MatsuhisaM. Oxidative stress and the JNK pathway are involved in the development of type 1 and type 2 diabetes. Curr Mol Med, 7: 674–686, 2007.
20.
KangZF, DengY, ZhouY, FanRR, ChanJC, LaybuttDR, LuzuriagaJ, and XuG. Pharmacological reduction of NEFA restores the efficacy of incretin-based therapies through GLP-1 receptor signalling in the beta cell in mouse models of diabetes. Diabetologia, 56: 423–433, 2013.
21.
KendrickAA, ChoudhuryM, RahmanSM, McCurdyCE, FriederichM, Van HoveJL, WatsonPA, BirdseyN, BaoJ, GiusD, SackMN, JingE, KahnCR, FriedmanJE, and JonscherKR. Fatty liver is associated with reduced SIRT3 activity and mitochondrial protein hyperacetylation. Biochem J, 433: 505–514, 2011.
KoyamaT, KumeS, KoyaD, ArakiS, IsshikiK, Chin-KanasakiM, SugimotoT, HanedaM, SugayaT, KashiwagiA, MaegawaH, and UzuT. SIRT3 attenuates palmitate-induced ROS production and inflammation in proximal tubular cells. Free Radic Biol Med, 51: 1258–1267, 2011.
24.
KushnerJA. The role of aging upon beta cell turnover. J Clin Invest, 123: 990–995, 2013.
25.
LantierL, WilliamsAS, WilliamsIM, YangKK, BracyDP, GoelzerM, JamesFD, GiusD, and WassermanDH. SIRT3 is crucial for maintaining skeletal muscle insulin action and protects against severe insulin resistance in high-fat-fed mice. Diabetes, 64: 3081–3092, 2015.
McDonnellE, PetersonBS, BomzeHM, and HirscheyMD. SIRT3 regulates progression and development of diseases of aging. Trends Endocrinol Metab, 26: 486–492, 2015.
29.
NoguchiH, NakaiY, UedaM, MasuiY, FutakiS, KobayashiN, HayashiS, and MatsumotoS. Activation of c-Jun NH2-terminal kinase (JNK) pathway during islet transplantation and prevention of islet graft loss by intraportal injection of JNK inhibitor. Diabetologia, 50: 612–619, 2007.
30.
PeyotML, PepinE, LamontagneJ, LatourMG, ZarroukiB, LussierR, PinedaM, JettonTL, MadirajuSR, JolyE, and PrentkiM. Beta-cell failure in diet-induced obese mice stratified according to body weight gain: secretory dysfunction and altered islet lipid metabolism without steatosis or reduced beta-cell mass. Diabetes, 59: 2178–2187, 2010.
31.
QiuX, BrownK, HirscheyMD, VerdinE, and ChenD. Calorie restriction reduces oxidative stress by SIRT3-mediated SOD2 activation. Cell Metab, 12: 662–667, 2010.
32.
RobertsonRP. Chronic oxidative stress as a central mechanism for glucose toxicity in pancreatic islet beta cells in diabetes. J Biol Chem, 279: 42351–42354, 2004.
33.
RobertsonRP, HarmonJ, TranPO, and PoitoutV. Beta-cell glucose toxicity, lipotoxicity, and chronic oxidative stress in type 2 diabetes. Diabetes 53 Suppl, 1: S119–S24, 2004.
34.
SakaiK, MatsumotoK, NishikawaT, SuefujiM, NakamaruK, HirashimaY, KawashimaJ, ShirotaniT, IchinoseK, BrownleeM, and ArakiE. Mitochondrial reactive oxygen species reduce insulin secretion by pancreatic beta-cells. Biochem Biophys Res Commun, 300: 216–222, 2003.
35.
SakurabaH, MizukamiH, YagihashiN, WadaR, HanyuC, and YagihashiS. Reduced beta-cell mass and expression of oxidative stress-related DNA damage in the islet of Japanese Type II diabetic patients. Diabetologia, 45: 85–96, 2002.
36.
ShiT, FanGQ, and XiaoSD. SIRT3 reduces lipid accumulation via AMPK activation in human hepatic cells. J Dig Dis, 11: 55–62, 2010.
37.
ShiT, WangF, StierenE, and TongQ. SIRT3, a mitochondrial sirtuin deacetylase, regulates mitochondrial function and thermogenesis in brown adipocytes. J Biol Chem, 280: 13560–13567, 2005.
38.
SolinasG and KarinM. JNK1 and IKKbeta: molecular links between obesity and metabolic dysfunction. FASEB J, 24: 2596–2611, 2010.
39.
SomeyaS, YuW, HallowsWC, XuJ, VannJM, LeeuwenburghC, TanokuraM, DenuJM, and ProllaTA. Sirt3 mediates reduction of oxidative damage and prevention of age-related hearing loss under caloric restriction. Cell, 143: 802–812, 2010.
YangL, ZhangJ, XingW, ZhangX, XuJ, ZhangH, ChenL, NingX, JiG, LiJ, ZhaoQ, and GaoF. SIRT3 deficiency induces endothelial insulin resistance and blunts endothelial-dependent vasorelaxation in mice and human with obesity. Sci Rep, 6: 23366, 2016.
42.
YoonJC, XuG, DeeneyJT, YangSN, RheeJ, PuigserverP, LevensAR, YangR, ZhangCY, LowellBB, BerggrenPO, NewgardCB, Bonner-WeirS, WeirG, and SpiegelmanBM. Suppression of beta cell energy metabolism and insulin release by PGC-1alpha. Dev Cell, 5: 73–83, 2003.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
